BDBM37586 4-[[(2-morpholin-4-yl-3,4-dioxocyclobuten-1-yl)amino]methyl]-N-(1,2,3,4-tetrahydronaphthalen-1-yl)benzamide::4-[[(3,4-diketo-2-morpholino-cyclobuten-1-yl)amino]methyl]-N-tetralin-1-yl-benzamide::4-[[[2-(4-morpholinyl)-3,4-dioxo-1-cyclobutenyl]amino]methyl]-N-(1,2,3,4-tetrahydronaphthalen-1-yl)benzamide::4-[[[2-morpholin-4-yl-3,4-bis(oxidanylidene)cyclobuten-1-yl]amino]methyl]-N-(1,2,3,4-tetrahydronaphthalen-1-yl)benzamide::MLS000119682::SMR000096603::cid_5308047
SMILES O=C(NC1CCCc2ccccc12)c1ccc(CNc2c(N3CCOCC3)c(=O)c2=O)cc1
InChI Key InChIKey=TUUNLUNWLLCMGW-UHFFFAOYSA-N
Data 1 IC50
Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB
Found 1 hit for monomerid = 37586
TargetHuntingtin(Homo sapiens (Human))
Columbia University Molecular Screening Center
Curated by PubChem BioAssay
Columbia University Molecular Screening Center
Curated by PubChem BioAssay
Affinity DataIC50: >8.00E+3nMAssay Description:The mutation underlying Huntington's disease is an expansion of a polyglutamine tract in the N-terminus of the protein huntingtin (htt). Under no...More data for this Ligand-Target Pair